So that they can identify agonists of LILRB2 that are stronger and steady than Angptl to aid ex vivo expansion of human HSCs, we discovered that immobilized polyclonal anti-LILRB2 facilitates consistent ex vivo expansion of human cord blood HSCs
So that they can identify agonists of LILRB2 that are stronger and steady than Angptl to aid ex vivo expansion of human HSCs, we discovered that immobilized polyclonal anti-LILRB2 facilitates consistent ex vivo expansion of human cord blood HSCs. serum-free tradition containing described cytokines and immobilized anti-LILRB2 that facilitates a net development of repopulating human… Read More »